Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct;3(10):2407-14.
doi: 10.1002/j.1460-2075.1984.tb02147.x.

Control of pT181 replication II. Mutational analysis

Control of pT181 replication II. Mutational analysis

S Carleton et al. EMBO J. 1984 Oct.

Abstract

We describe the isolation and analysis of mutations affecting the regulation of Staphylococcus aureus plasmid pT181 replication. Previous results suggested that regulation is achieved by control of the synthesis of RepC, a plasmid-coded replication protein and that the primary negative control element is CopA RNA, which consists of two transcripts that are complementary to the 5' region of the repC mRNA leader. CopA inhibition probably involves a base pairing interaction with the complementary region of the RepC mRNA leader which would facilitate the formation of a downstream stem-loop in the leader that occludes the repC ribosome binding site. RepC is freely diffusible so that regulation of pT181 replication is indirect. Both CopA RNA-sensitive (recessive) and -insensitive (dominant) mutants were isolated. The recessives have defects in CopA RNA structure or activity, the dominants have defects in the site of action (target) of the inhibitor. Some dominants were located within the copA coding sequence. These therefore affect the structure of CopA RNA as well as that of its target. Other dominant mutations mapped outside of the copA gene and therefore produced wild-type CopA RNA. In contrast to directly regulated plasmids, pT181 copy mutants producing wild-type inhibitor could be co-maintained with the wild-type plasmid and mutational changes in inhibitor-target specificity did not change incompatibility specificity.

PubMed Disclaimer

References

    1. Virology. 1967 Sep;33(1):155-66 - PubMed
    1. J Gen Microbiol. 1970 Dec;64(3):377-80 - PubMed
    1. J Mol Biol. 1972 Jul 21;68(2):285-302 - PubMed
    1. J Bacteriol. 1975 Oct;124(1):201-11 - PubMed
    1. Arch Roum Pathol Exp Microbiol. 1976 Jan-Jun;35(1-2):111-8 - PubMed

Publication types